Our current and recently published (18) data suggest that, irrespective of the expression of activating point mutations in K-ras, pancreatic cancer is highly sensitive to the cancer-stimulating effects of stress neurotransmitter driven responses to psychological stress. The gene discussed is KRAS; the disease is familial pancreatic carcinoma.